Astellas Pharma US, Inc. announced that it has launched a new application for smartphones. The application is the Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging (RNI). It aims to allow doctors to review the published criteria used to determine a patient’s need to undergo RNI procedure. The recently alunched application can be downloaded for free, and it works on several platforms such as BlackBerry®, Android™, and iPhone®. The data included in the Appropriate Use Criteria (AUC) for RNI was taken from the ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging (RNI), which was published back in 2009.
The new Application and RNI
AUC for RNI procedures has 67 patient indications, 8 indication categories, in addition to 5 algorithms. Using Astellas' application, doctors will be able to follow a step-by-step evaluation process to determine the need for conducing RNI procedure. The evaluation includes patient history, clinical picture, and several other relevant factors. The doctors will have a score for RNI, which will range between1 to 9. So the procedure will be considered inappropriate (1-3), uncertain (4-6), or appropriate (7-9) based on the generated RNI score. Robert C. Hendel, MD, FACC, FAHA, FASNC, and Chair of the Cardiac Radionuclide Imaging Writing Group that developed the 2009 AUC for RNI, said "Astellas recognizes physicians are increasingly using smartphones and apps in the healthcare setting to access information. We partnered with them to develop this accurate, timely, assessment tool for use on smartphones and hope this app will promote awareness and use of the AUC for RNI published in 2009,"